News
cataract
Ocular inflammation drug to head to phase 3 clinical trial
Harrow, the manufacturer of TRIESENCE, hopes to expand the on-label usage of TRIESENCE for all cataract surgery patients.
geographic atrophy
Positive clinical trial results of wireless retinal implant
Results of a clinical trial testing a new wireless retinal implant were recently published in the New England Journal of Medicine.
Alzheimer's
Alzheimer's risk associate with common bacteria
A common bacteria that causes sinus infections and pneumonia may increase the risk of Alzheimer's.
Axpaxli
Successful Phase 3 study results for Ocular's Axpaxli wet AMD drug
Ocular Therpeutix announced successful results of their experimental drug Axpaxli in treating wet age-related macular degeneration.
diabetic retinopathy
The gut connection to diabetic retinopathy
Study results recently published in Gut, highlight the role that gut microbiome plays in diabetic retinopathy.
age-related macular degeneration
Diabetic drug associated with lower risk of progression of age-related macular degeneration
Drug commonly used to treat diabetes may lower risk of progression of age-related macular degeneration.
age related macular degeneration
Parkinson's medication may help lower risk progression of age-related macular degeneration
Levodopa is commonly prescribed to treat Parkinson's disease and a recent study found that it could possibly reduce the risk of progression from dry age-related macular degeneration (AMD) to the we...
age-related macular degeneration
Stem cell retinal implant enters phase 2b testing
Researchers at the Roski Eye Institute are testing a stem cell retinal implant as a possible treatment for advanced dry age-related macular degeneration.
age-related macular degeneration
Correlation between cardiovascular risk and risk of developing eye diseases found
Recent study results highlight the association between an individual's cardiovascular risk score and their odds of developing certain eye diseases.